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Background: Scar burden independently predicts mortality in patients with severe ischemic cardiomyopathy (ICM). Previous studies have also 
demonstrated differential survival in patients with ICM based on gender. We sought to assess impact of gender and scar burden (SB) with outcomes 
in patients with ICM, with and without ICD. 
Methods: 450 patients with ≥ 70% stenosis in ≥1 epicardial coronary artery underwent delayed hyperenhancement-MRI (Siemens 1.5-T scanner, 
Erlangen, Germany) between 2003-2006. 163 patients underwent subsequent ICD (77% men, median age 63 years, median LV ejection fraction 
21 %, median SB 30% ). Cox proportional hazards survival modeling, using a primary end-point of all-cause mortality, was used to risk-adjust 
comparisons. 
Results: Over a follow-up of up to 9 years[mean 5.8years], 186 deaths [128 of 339 men (38%) and 58 of 111 women (52%)] occurred. Amongst 
the 163 patients with ICD, 62 deaths occurred [47 of 126 men (37%), and 15 of 37 women 41%)]. Survival analysis revealed that after adjusting 
for subsequent CABG, age, mitral regurgitation, and ESVi, ICD (r2 5.19, p = 0.022), female gender (r2 12.69, p=0.013), and SB (r2 19.66, p = 
<0.001) were independent predictors of mortality. Women had significantly increased survival benefit compared to men in the setting of ICD and 
smaller SB. However, women had minimal survival benefit compared to men with ICD and higher SB . (Figure 1).
Conclusions: MSB predict gender-based differences in mortality benefit with ICD, in patients with severe ICM.
 
